Product image of Irbesartan Mylan (Irbesartan) supplied by GNH India

Irbesartan Mylan

Active Ingredient:
Irbesartan
Origin:
EU

Irbesartan Mylan (Irbesartan)

Irbesartan, the active ingredient in Irbesartan Mylan, is an angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It is indicated for the treatment of hypertension and for slowing the progression of diabetic nephropathy, helping to control blood pressure and reduce renal stress in adult patients.

GNH India supplies Irbesartan Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance and reliable logistics across multiple regions.

Manufacturer / TM Owner

Viatris Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Irbesartan is an angiotensin II receptor blocker used to treat conditions related to the renin‑angiotensin system.

  • Hypertension: lowers elevated blood pressure and reduces cardiovascular risk.
  • Diabetic nephropathy: slows kidney function decline in patients with type 2 diabetes.
  • Proteinuria associated with diabetic kidney disease: decreases urinary protein excretion, supporting renal protection.

How It Works

  • Irbesartan selectively blocks angiotensin II type 1 (AT1) receptors, preventing angiotensin II‑mediated vasoconstriction, aldosterone release, and sympathetic activation. This inhibition leads to vasodilation, reduced sodium and water retention, and decreased peripheral resistance, thereby lowering systemic blood pressure and providing renal protective effects in diabetic patients.

Side Effects

Common Side Effects

  • Dizziness: sensation of light‑headedness, especially after standing.
  • Headache: mild to moderate pain in the head region.
  • Fatigue: feeling unusually tired or weak.
  • Upper respiratory tract infection: symptoms such as sore throat or nasal congestion.
  • Nausea: mild stomach discomfort or urge to vomit.
  • Diarrhea: loose stools occurring intermittently.

Serious or Rare Side Effects

  • Angioedema: swelling of the face, lips, tongue, or throat that may compromise breathing.
  • Hyperkalemia: elevated potassium levels that can affect heart rhythm.
  • Acute kidney injury: sudden decline in renal function, indicated by rising creatinine.
  • Hepatic injury: abnormal liver enzymes or jaundice indicating liver stress.

Precautions & Warnings

Before starting Irbesartan, patients should consider the following precautions:

  • Blood pressure monitoring: regularly check to ensure therapeutic control.
  • Renal function assessment: evaluate serum creatinine and eGFR before and during therapy.
  • Serum potassium measurement: monitor for hyperkalemia, especially with concomitant potassium‑sparing agents.
  • Pregnancy: avoid use as safety in pregnancy is unknown; discuss alternatives with a healthcare professional.
  • Hepatic impairment: use with caution in patients with liver disease.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Irbesartan may interact with several medicines. Review the following groups:

Major Interactions (Avoid)

  • Aliskiren (in diabetic patients): combined use can increase renal risk.
  • Dual ARB/ACE‑inhibitor therapy: may cause excessive potassium rise and kidney dysfunction.
  • Potassium‑sparing diuretics (e.g., spironolactone): heightens risk of hyperkalemia.

Moderate Interactions (Monitor Closely)

  • NSAIDs (e.g., ibuprofen): can reduce antihypertensive effect and impair renal function.
  • Lithium: may increase lithium concentrations, requiring serum level checks.

Frequently Asked Questions

Irbesartan Mylan is prescribed to lower high blood pressure (hypertension) and to protect kidney function in adults with diabetic nephropathy. By controlling blood pressure, it helps reduce the risk of cardiovascular events and slows the progression of kidney damage associated with diabetes.

Irbesartan blocks the angiotensin II type 1 (AT1) receptors, preventing angiotensin II from causing blood vessels to narrow and from stimulating aldosterone release. This results in vasodilation, reduced fluid retention, and lower blood pressure, while also decreasing stress on the kidneys in diabetic patients.

The appropriate dose of Irbesartan Mylan is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and any other medications being taken. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of Irbesartan during pregnancy has not been established, and it is generally avoided because of potential risks to the fetus. Limited data exist for breastfeeding; therefore, a healthcare provider should evaluate the benefits and risks before use in nursing mothers.

To place an order, submit an enquiry on the Irbesartan Mylan product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Irbesartan belongs to the ARB class, which offers blood‑pressure control similar to ACE inhibitors but with a lower incidence of cough and angioedema. Compared with calcium‑channel blockers, ARBs target the renin‑angiotensin system directly, making them especially useful for patients with diabetic kidney disease.

Irbesartan Mylan tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Irbesartan Mylan is taken orally, usually with or without food, as a whole tablet. Patients should swallow the tablet with a full glass of water and follow the dosing schedule prescribed by their healthcare professional.

The most serious risks include angioedema, which can cause swelling of the face or throat and threaten breathing, and hyperkalemia, a potentially dangerous rise in blood potassium that may affect heart rhythm. Acute kidney injury is another critical concern, especially when combined with other nephrotoxic agents.

Irbesartan Mylan should not be used by individuals with known hypersensitivity to irbesartan or any component of the formulation. It is also contraindicated in patients with severe hepatic impairment and should be avoided in pregnancy due to unknown fetal safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Irbesartan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT